SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Trading Cabana -- Ignore unavailable to you. Want to Upgrade?

To: ajs who wrote (356)7/7/2004 7:30:58 AM
From: Hank  Respond to of 6370
 
It was hyping a treatment for erectile disfunction that had poor efficacy, a high probability of adverse side effects, and never stood a chance in the market place against drugs like Viagra. Plus, the drug being used in the product was a generic compound that had been around for years. Not surprisingly, the FDA shot it down. They hyped their stock price based on weak clinic data and sold the "story" using multiple hyped up press releases.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News